Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 4/12/2019
SIETES contiene 92848 citas

 
 
 1 a 20 de 194 siguiente >>
Presentar resultados
Seleccionar todas
1.Enlace a cita original Cita con resumen
Dvorin EL, Lamb MC, Monlezun DJ, Boese AC, Bazzano LA, Price-Haywood EG. High frequency of systemic corticosteroid use for acute respiratory tract illnesses in ambulatory settings. JAMA Intern Med 2018;178:junio. [Ref.ID 102772]
2. Cita con resumen
Poluzzi E, Diemberger I, de Ridder M, Koci A, Clo M, Oteri A, Pecchioli S, Bezemer I, Schink T, Ulrichsen SP, Boriani G, Sturkenboom MCJ, De Ponti F, Trifirò G. Use of antihistamines and risk of ventricular tachyarrhythmia: a nested case-control study in five European countries from the ARITMO project. Eur J Clin Pharmacol 2017;73:1499-510. [Ref.ID 102126]
3.Tiene citas relacionadas Cita con resumen
Meltzer EO, Ratner PH, McGraw T. Oral phenylephrine HCl for nasal congestion in seasonal allergic rhinitis: a randomized, open-label, placebo-controlled study. J Allergy Clin Immunol 2015;3:702-8. [Ref.ID 99480]
4.Enlace a cita original Cita con resumen
Anónimo. Corticoides nasales. Infac: Información Farmacoterapéutica de la Comarca 2015;23:1-5. [Ref.ID 98948]
5. Cita con resumen
Rajan JP, Wineinger NE, Stevenson DD, White AA. Prevalence of aspirin-exacerbated respiratory disease among asthmatic patients: a meta-analysis of the literature. J Allergy Clin Immunol 2015;135:676-81. [Ref.ID 98839]
6. Cita con resumen
Anónimo. Azelastine and fluticasone nasal spray: any advantage?. Drug Ther Bull 2014;52:21-4. [Ref.ID 97105]
7.Tiene citas relacionadas
Nelson HS. Is sublingual immunotherapy ready for use in the United States?. JAMA 2013;309:1297-8. [Ref.ID 95145]
8.Enlace a cita originalTiene citas relacionadas Cita con resumen
Lin SY, Erekosima N, Kim JM, Ramanathan M, Suarez-Cuervo C, Chelladurai Y, Ward D, Segal JB. Sublingual immunotherapy for the treatment of allergic rhinoconjunctivitis and asthma: a systematic review. JAMA 2013;309:1278-88. [Ref.ID 95141]
9.Tiene citas relacionadas Cita con resumen
Coeytaux RR, Park JJ. Acupuncture research in the era of comparative effectiveness research. Ann Intern Med 2013;158:287. [Ref.ID 94955]
10.Tiene citas relacionadas Cita con resumen
Brinkhaus B, Ortiz M, Witt CM, Roll S, Linde K, Pfab F, Niggemann B, Hummelsberger J, Treszl A, Ring JZ, Zuberbier T, Wegscheider K, Willich SN. Acupuncture in patients with seasonal allergic rhinitis: a randomized trial. Ann Intern Med 2013;158:225-34. [Ref.ID 94953]
11. Cita con resumen
Smith SR, Montgomery LG, Williams JW Jr. Treatment of mild to moderate sinusitis. Arch Intern Med 2012;172:510-3. [Ref.ID 92565]
12. Cita con resumen
Garbutt JM, Banister C, Spitznagel E, Piccirillo JF. Amoxicillin for acute rhinosinusitis: a randomized controlled trial. JAMA 2012;307:685-92. [Ref.ID 92367]
13.Tiene citas relacionadas Cita con resumen
Mullol J, Alobid I. Combined oral and intranasal corticosteroid therapy: and advance in the management of nasal polyposis?. Ann Intern Med 2011;154:365-7. [Ref.ID 91164]
14.Tiene citas relacionadas Cita con resumen
Vaidyanothan S, Bames M, Williamson P, Hopkinson P, Donnan PT, Lipworth B. Treatment of chronic rhinosinusitis with nasal polyposis with oral steroids followed by topical steroids. A randomized trial. Ann Intern Med 2011;154:293-302. [Ref.ID 91163]
15. Cita con resumen
Anónimo. Phleum pratense, extracto de polen. Boletín Terapéutico Andaluz - Ficha de novedad terapéutica 2010;26:1-4. [Ref.ID 89894]
16. Cita con resumen
Beasley RW, Clayton TO, Crane J, Lai CKW, Montefort SR, von Motius E, Stewart AW, and the ISAAC Phase Three Study Group. Acetaminophen use and risk of asthma, rhinoconjunctivitis and eczema in adolescents: ISAAC Pphase three . Am J Respir Crit Care Med 2011;183:171-8. [Ref.ID 88943]
17. Cita con resumen
Anónimo. Cétirizine et loratadine: un risque minime d'allongement de l'intervalle QT. Prescrire 2009;29:753-5. [Ref.ID 86779]
18.
Valero A, de la Torre F, Castillo JA, Rivas P, del Cuvillo A, Antépara I, Borja J, Donado E, Molà O, Izquierdo I. Safety of rupatadine administered over a period of 1 year in the treatment of persistent allergic rhinitis: a multicentre, open-label study in Spain. Drug Saf 2009;32:33-42. [Ref.ID 85095]
19.Tiene citas relacionadas Cita con resumen
Lawyer AB. Paracetamol as a risk factor for allergic disorders. Lancet 2009;373:121. [Ref.ID 85002]
20.Tiene citas relacionadas Cita con resumen
Beasley R, Clayton T, Crane J, von Mutius E, Lai CKW. Paracetamol as a risk factor for allergic disorders. Authors' reply. Lancet 2009;373:120-1. [Ref.ID 85001]
Seleccionar todas
 
 1 a 20 de 194 siguiente >>